Epigenetic control of microglial immune responses
Immunological Reviews · 2024-05 · 323 (1) · 209-226
DOI: 10.1111/imr.13317 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 16.03.2024. Verfasst von Rebekka Scholz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. Hauptthemen laut MEDLINE: Microglia, Epigenesis, Genetic. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gemeinnützige Hertie-Stiftung, Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Microglia, the major population of brain‐resident macrophages, are now recognized as a heterogeneous population comprising several cell subtypes with different (so far mostly supposed) functions in health and disease. A number of studies have performed molecular characterization of these different microglial activation states over the last years making use of “omics” technologies, that is transcriptomics, proteomics and, less frequently, epigenomics profiling. These approaches offer the possibility to identify disease mechanisms, discover novel diagnostic biomarkers, and develop new therapeutic strategies. Here, we focus on epigenetic profiling as a means to understand microglial immune responses beyond what other omics methods can offer, that is, revealing past and present molecular responses, gene regulatory networks and potential future response trajectories, and defining cell subtype‐specific disease relevance through mapping non‐coding genetic variants. We review the current knowledge in the field regarding epigenetic regulation of microglial identity and function, provide an exemplary analysis that demonstrates the advantages of performing joint transcriptomic and epigenomic profiling of single microglial cells and discuss how comprehensive epigenetic analyses may enhance our understanding of microglial pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
- Biomedical Center (BMC), Biochemistry, Faculty of Medicine, LMU Munich, Munich, Germany.
- Neuroimmunology and Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
- Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
ORCID-Profile: Rebekka Scholz, Jonas J Neher
Förderung
- Gemeinnützige Hertie-Stiftung
- Else Kröner-Fresenius-Stiftung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Scholz, R., Brösamle, D., Yuan, X., Beyer, M., & Neher, J. J. (2024). Epigenetic control of microglial immune responses. Immunological Reviews, 323(1), 209-226. https://doi.org/10.1111/imr.13317
Vancouver
Scholz R, Brösamle D, Yuan X, Beyer M, Neher JJ. Epigenetic control of microglial immune responses. Immunological Reviews. 2024;323(1):209-226. doi:10.1111/imr.13317
BibTeX
@article{Scholz2024,
author = {Scholz, Rebekka and Brösamle, Desirée and Yuan, Xidi and Beyer, Marc and Neher, Jonas J},
title = {Epigenetic control of microglial immune responses},
journal = {Immunological Reviews},
year = {2024},
volume = {323},
number = {1},
pages = {209--226},
doi = {10.1111/imr.13317}
}
EUVIMED